Gene · 10642
Papers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,895
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer. | Int J Mol Sci | 2024 | 38891888 | PubTator, text mining | PubMed |
| A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning. | Transl Psychiatry | 2024 | 38886359 | PubTator, text mining | PubMed |
| Clinical and Microbiological Characteristics of Bacteremia Caused by Carbapenemase-producing Enterobacterales in Minami Ibaraki Area, Japan. | J Microorg Control | 2024 | 38880620 | PubTator, text mining | PubMed |
| Molecular insights into regulatory RNAs in the cellular machinery. | Exp Mol Med | 2024 | 38871819 | PubTator, text mining | PubMed |
| Duck pan-genome reveals two transposon insertions caused bodyweight enlarging and white plumage phenotype formation during evolution. | Imeta | 2024 | 38868520 | PubTator, text mining | PubMed |
| Systematic analysis of IGF2BP family members in non-small-cell lung cancer. | Hum Genomics | 2024 | 38867248 | PubTator, text mining | PubMed |
| METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1. | Biol Direct | 2024 | 38849910 | PubTator, text mining | PubMed |
| m6a methylation orchestrates IMP1 regulation of microtubules during human neuronal differentiation. | Nat Commun | 2024 | 38844464 | PubTator, text mining | PubMed |
| Comprehensive analysis of the functions, prognostic and diagnostic values of RNA binding proteins in head and neck squamous cell carcinoma. | J Stomatol Oral Maxillofac Surg | 2024 | 38844022 | PubTator, text mining | PubMed |
| Intrinsic Epigenetic State of Primary Osteosarcoma Drives Metastasis. | Mol Cancer Res | 2024 | 38842581 | PubTator, text mining | PubMed |
| METTL3 promotes the osteogenic differentiation of human periodontal ligament cells by increasing YAP activity via IGF2BP1 and YTHDF1-mediated m6A modification. | J Periodontal Res | 2024 | 38838034 | PubTator, text mining | PubMed |
| Oridonin represses lung cancer cell proliferation and migration by modulating AFAP1-AS1/IGF2BP1. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38836673 | PubTator, text mining | PubMed |
| IGF2BP1 Bolsters the Chondrocytes Ferroptosis of Osteoarthritis by Targeting m6A/MMP3 Axis. | Int J Gen Med | 2024 | 38826510 | PubTator, text mining | PubMed |
| Implications of GCLC in prognosis and immunity of lung adenocarcinoma and multi-omics regulation mechanisms. | BMC Pulm Med | 2024 | 38750474 | PubTator, text mining | PubMed |
| Multi-omics in MECP2 duplication syndrome patients and carriers. | Eur J Neurosci | 2024 | 38746988 | PubTator, text mining | PubMed |
| Author Response. | Indian J Crit Care Med | 2024 | 38738190 | PubTator, text mining | PubMed |
| Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis. | Cell Signal | 2024 | 38729321 | PubTator, text mining | PubMed |
| Identification of Breast Cancer Subtypes Based on Endoplasmic Reticulum Stress-Related Genes and Analysis of Prognosis and Immune Microenvironment in Breast Cancer Patients. | Technol Cancer Res Treat | 2024 | 38725284 | PubTator, text mining | PubMed |
| Increased PTCHD4 expression via m6A modification of PTCHD4 mRNA promotes senescent cell survival. | Nucleic Acids Res | 2024 | 38721764 | PubTator, text mining | PubMed |
| Transcriptional repression of the oncofetal LIN28B gene by the transcription factor SOX6. | Sci Rep | 2024 | 38704454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10642/papers?page=17